Multiple Sclerosis – Modus Health

J. E. Sasaki, G. F. A. Bertochi, J. Meneguci, R. W. Motl. Pedometers and Accelerometers in Multiple Sclerosis: Current and New Applications. International Journal of Environmental Research and Public Health 2022; 19(18):11839

R. W. Motl, B. M. Sandroff, R. H. Benedict. Moderate-to-vigorous physical activity is associated with processing speed, but not learning and memory, in cognitively impaired persons with multiple sclerosis. Multiple Sclerosis and Related Disorders 2022; 63:103833

C. M. McDonald. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 2002; 81(11 Suppl):S108-20.

A. Neven, A. Vanderstraeten, D. Janssens, G. Wets, P. Feys. Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability. Neurol Sci 2016; 37(9):1483-90.

T. R. Brown, V. I. Simnad. A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis. Int J MS Care 2016; 18(4):170-6.

B. M. Sandroff, R. W. Motl, L. A. Pilutti, et al. Accuracy of StepWatch and ActiGraph accelerometers for measuring steps taken among persons with multiple sclerosis. PLoS One 2014; 9(4):e93511.

R. W. Motl, Y. C. Learmonth. Neurological disability and its association with walking impairment in multiple sclerosis: brief review. Neurodegener Dis Manag 2014; 4(6):491-500.

P. Filipovic Grcic, M. Matijaca, I. Bilic, et al. Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients. Acta Neurol Belg 2013.

R. W. Motl, B. M. Sandroff, J. J. Sosnoff. Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis. Expert Rev Neurother 2012; 12(9):1079-88.

A. L. Schmidt, M. L. Pennypacker, A. H. Thrush, C. I. Leiper, R. L. Craik. Validity of the StepWatch Step Activity Monitor: preliminary findings for use in persons with Parkinson disease and multiple sclerosis. J Geriatr Phys Ther 2011; 34(1):41-45.